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Organ specific autoimmune diseases are relatively common immunological disorders inman which include thyroid autoimmune disease, insulin- 
dependent diabetes mellitus and myasthenia gravis. The target autoantigens i  ome of these diseases have recently been characterised. In thyroid 
autoimmune disease this includes the key enzyme, thyroid peroxidase (TPO), which is involved in the generation fthyroid hormone. Structural 
knowledge about autoantigens such as thyroid peroxidase will allow a greater understanding of the interaction between autoantigens and the aber- 
rant immune response, and facilitate the development of strategies for antigen-specific therapeutic manipulation. We report here a prediction of 
the secondary structure ofthyroid peroxidase, together with the results of circular dichroic spectroscopy of ahomologous purified enzyme. A combi- 
nation of 3 secondary structure prediction programs has been used, following multiple sequence alignment, and TPO has been found to consist 
mainly of ~t-helical conformation, with little p-sheet present. This structure prediction, together with knowledge ofthe exon-intron boundaries allows 
a model for the domain organisation f the TPO molecule tobe proposed. 
Thyroid peroxidase; Autoantigen; Myeloperoxidase; Circular dichroic spectroscopy; Secondary structure prediction 
1. INTRODUCTION 
Autoimmune lymphocytic thyroiditis is a relatively 
common condition affecting 5% of the general popula- 
tion, with a higher incidence in women than men [1]. 
The disease is characterised by the production of au- 
toantibodies (aAbs) to a number of thyroid cell consti- 
tuents including thyroglobulin (Tg) and the thyroid 
microsomal antigen. The thyroid microsomal antigen is 
likely to be the target autoantigen i destructive thyroid 
disease leading to thyroid failure [2]. We first showed 
this antigen to be a 105 kDa protein [3], which has been 
shown to be identical to thyroid peroxidase (TPO), the 
key enzyme involved in the generation of thyroid hor- 
mones from their 'pro-hormone' Tg [4]. The aAb 
response to TPO is known to be polyclonal, and several 
autoantigenic sites have been recognized [5,6]. 
Amongst the spectrum of aAbs detected are those 
which, being directed towards the active site of the 
molecule, inhibit enzymatic activity [5-7]. 
The complete amino acid sequence of TPO has 
recently been deduced from cDNA cloning [8]. This 
revealed the presence of two different forms of mRNA 
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derived by alternative splicing of a single gene product 
[8]. The two forms of TPO, termed TPO-1 and TPO-2, 
have been fully sequenced and indicate that 57 residues 
are deleted in the shorter, TPO-2 form of the molecule 
[8,9]. The amino acid sequence of TPO exhibits a high 
degree of sequence similarity (42o70 identity) to myelo- 
peroxidase (MPO) [10,11]. Furthermore, the structure 
of the TPO and MPO genes have recently been 
elucidated [12,13]. A comparison of the two gene se- 
quences reveals that the exon-intron boundaries in both 
the peroxidases are highly conserved [13]. The close 
relationship between TPO and MPO is also manifest 
antigenically with some aAbs to TPO obtained from 
autoimmune thyroid disease patients cross-reacting 
with MPO [14]. A detailed knowledge of the three- 
dimensional structure and an accurate localization of 
the autoantigenic epitopes on the TPO molecule would 
greatly increase our understanding of the autoimmune 
response to this autoantigen and allow the development 
of future strategies for immune intervention to prevent 
or reverse the course of the disease [15,16]. 
In order to elucidate secondary or tertiary structure, 
it is necessary to have access to milligram amounts of 
purified protein for structural analysis. We are able to 
purify by HPLC techniques a few hundred microgram 
amounts of enriched etergent-solubilized, intact TPO 
(approximate purity 600/0) from human thyroid glands 
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for immunological studies [17], but it is currently not 
possible to obtain sufficient human thyroid glands for 
preparation of enough pure TPO for structural studies. 
Trypsinized TPO from porcine thyroid glands (pTPO) 
can be prepared in larger quantities, but this lacks ap- 
proximately 90 residues at the amino- and carboxyl- 
terminals and also contains a trypsin cleaved site after 
residue 561 [18]. Such a sample was used for structural 
studies reported below. However, highly purified 
preparations of intact, water-soluble human MPO 
(hMPO) have been obtained for immunological in- 
vestigations [14]. In view of the high sequence similarity 
between hMPO and human TPO (hTPO), we have used 
hMPO for circular dichroic (CD) spectroscopy and ex- 
trapolated the results to hTPO. In addition, multiple 
alignments [19] of the sequences of hTPO, pTPO and 
hMPO have been performed using the algorithm of 
Barton and Sternberg [20,21]. By applying 3 indepen- 
dent secondary structure prediction methods to the 
multiply-aligned peroxidase sequences, it has been 
possible to predict the secondary structure and the 
organisation ofdomains in TPO. By combining the CD 
spectral information on MPO with the secondary struc- 
ture prediction of TPO, we show that the structure of 
TPO is mainly a-helical with little fl-sheet, and is 
organised into distinct domains. 
2. MATERIALS AND METHODS 
2.1. Preparation of MPO for CD analysis 
hMPO was isolated from neutrophils purified from blood packs of 
normal donor blood. The final step in the purification procedure in- 
cluded isoelectric focusing in Sephadex G-25 yielding MPO prepara- 
tions of > 90% purity [141. Trypsinized pTPO (of purity > 90%) was 
prepared as described [18], and was a gift from Professor A. Taurog. 
2.2. CD spectral analysis 
hMPO was dissolved at 0.1 mg/ml in 0.1 M Tris-HCl, pH 7.4; tryp- 
sinised pTPO was resuspended at 0.1 mg/ml in phosphate-buffered 
saline. CD spectra were recorded on a Jasco J600 CD spectrometer in-
terfaced to an IBM PS/2 computer running commercial software. All 
spectra were run at room temperature in 0.05 cm 'strain-free' quartz 
cells and were corrected for solvent absorbance. 
2.3. Alignment of sequences and prediction techniques 
Multiple sequence alignment was performed automatically by the 
algorithm of Barton and Sternberg [20,21] using the AMPS package 
[19], whilst conservation values were defined using the protocol of 
Zvelebil et al. [22]. Turns were predicted using (i) the method of 
Wilmot and Thornton [23] (Program supplied by Dr C. Wilmot) and 
(ii) that of Rose [24]. a-Helix and B-strand regions were predicted us- 
ing the algorithms of Lim [25], Chou and Fasman [26] and Robson 
[27] as programmed in the Leeds prediction suite (Dr. E. Eliopoulos, 
Department of Biophysics, University of Leeds, Leeds, UK). The 
results of the alignment and annotated predictions were formatted us- 
ing the HOMED programme (Dr P.A. Stockwell, Department of 
Biochemistry, University of Otago, Otago, New Zealand). B-Cell 
defined epitopes were predicted using the Hopp and Woods profile 
[28] with the top 20 hydrophilic peaks considered for further analysis. 
T-Cell defined epitopes were predicted using the pattern matching 
technique of Taylor and Rothbard [29]. 
3. RESULTS AND DISCUSSION 
3.1. Analysis of  CD spectroscopy 
The far ultraviolet CD spectrum of hMPO was 
recorded in aqueous olution and exhibits a moderately 
broad band with a minimum in the 200-210 nm range 
(Fig. 1). The values of a-helical content were calculated 
to be approximately 55-600/o for hMPO (Table I), with 
the remainder of the protein in random coil conforma- 
tion. 
The CD spectrum of a trypsinized preparation of 
pTPO [18] was measured (not shown) and it also in- 
dicated a protein with only a-helical content (approx- 
imately 27-33070) and random coil conformation. The 
lower a-helical content in this preparation compared to 
hMPO may reflect he fact that the trypsinized pTPO 
preparation is a fragmented molecule. 
3.2. Analysis of hTPO, pTPO and hMPO sequence 
data 
3.2.1. Sequence alignment 
The multiple alignment of hTPO, pTPO and hMPO 
is shown in Fig. 2. The high level of similarity between 
the sequences (>50.0 SD from the mean of 100 ran- 
domized sequence scores), strongly suggests that the 
proteins hare a common ancestor, that their overall 
tertiary folds will be similar and also that the auto- 
matically obtained multiple alignment will be correct 
within common conserved secondary structural regions 
[20,21]. 
3.2.2. Combination of secondary structure prediction 
techniques 
Secondary structure prediction methods generally 
give around 55-65°7o accuracy for a 3-state prediction 
of helix, strand and non-helix/non-strand (i.e. coil) 
structure. However, combined prediction methods can 
yield improvements in accuracy [30] as can combining 
predictions on accurately aligned sequences [22]. Ac- 
cordingly, the 5 prediction methods were performed in- 
dependently on each aligned sequence, and then the 
results combined into a consensus. 
The fact that TPO and MPO exhibit a high degree of 
sequence [10,11] and considerable antigenic similarity 
[14] provides compelling evidence in favour of a similar 
secondary structure. Since the CD analysis indicates 
that hMPO is predominantly a-helical, the parameters 
for all helical proteins were applied in the Chou and 
Fasman prediction [26], whilst decision constants 
suitable for proteins of > 5007o a-helix and < 20°7o fl- 
structure were applied in the Robson prediction [27] 
(DCn = 100, DCE = 50). 
The results of the two turn prediction algorithms, i.e. 
a total of 6 predictions at each position, were combined 
by expressing the number of predictions that define 
each residue as part of a turn as a fraction of the total 
possible number of predicted turns. Similarly, predic- 
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Fig. ]. Circular dichroism (CD) spectrum of hMPO (purity >90070) in 
the far ultraviolet region in aqueous olution (0.1 mg/ml in 0.1 M 
Tris-HC1, pH 7.4) in 0.05 cm pathlength. AE is the extinction coeffi- 
cient. 
tions of helix, strand and coil were combined for the 9 
predictions (Lim [25], Chou and Fasman [26] and those 
of Robson [27] on each of the 3 sequences) ateach posi- 
tion. 
The consensus prediction shown in Fig. 2 was obtain- 
ed by taking the defined state to be that with the largest 
fraction predicted. For example, at aligned position 74, 
Wilmot and Thornton [23] predict involvement in a 
turn for hTPO, pTPO and hMPO whilst Rose [24] 
predicts turn for hTPO and pTPO; a total of 5/6 
predictions for turn. At the same position, Lim [25] 
predicts hMPO as ~, Robson [27] predicts hTPO and 
pTPO as fl, and hMPO as a, whilst Chou and Fasman 
[26] predict hTPO and hMPO as a. Thus, a and fl are 
equally predicted 3/9 at this position, by default, coil is 
predicted 3/9, whilst turn is predicted 5/6. Accordingly 
the consensus prediction is assigned as turn for this 
position. Where a tie occurs, the ambiguity is recorded 
for all tied combinations of H,B,T predicted at that 
position (see legend to Fig. 2). 
This approach to combining the methods highlights 
the strongly predicted a,/5' and turn regions, records 
ambiguity where it occurs, but leaves regions unassign- 
ed where only weakly predicted a or fl are indicated. 
For the purposes of discussion, these unassigned 
regions will be referred to as 'coil'; however, this is not 
meant to imply lack of defined structure, but merely 
that a, ~ or turn are not strongly predicted in these 
regions. 
Table I 
The estimation of the or-helical content of human MPO 
Wavelength (nm) Extinction coefficient % helix a 
(AE) (M- '" cm- 1) 
222 5.4 59.4 
225 4.8 55.2 
a remaining secondary structure is coil 
The overall result of this combined prediction for 
TPO is 31 07o a-helix, 9°7o ~'-sheet and 29070 turn, with the 
remaining 31 070 being defined as 'coil'. In the region of 
homology with MPO (residues 1-741) the percentages 
are a-helix 51070, ~-sheet 8°70, turn 41070 and the re- 
mainder as random coil. This compares well with the 
CD results howing a-helical conformation of 55-60% 
and the remainder as random coil. 
3.2.3. Additional Information used to assist prediction 
(i) Insertions/deletions. Further structural detail may 
be inferred from an alignment of two or more sequences 
by considering the residue conservation ateach aligned 
position. In particular, studies of aligned protein 
families for which the three-dimensional structure of 
more than one member isavailable [31] show that inser- 
tions and deletions normally occur in surface loop 
regions between regular secondary structures. Analysis 
of the peroxidase alignment (Fig. 2) shows only 4 inser- 
tions between the human and porcine TPO (insertion of 
E at 388 and L at 518 of hTPO and insertion of GK at 
896 and LPG at 903 of pTPO; see Table II). All 4 inser- 
tions are adjacent to Gly, Pro and charged amino acids 
which are frequently associated with turns or surface 
loop regions. The insertions are also adjacent to 
predicted turn and coil regions. These observations lend 
strong support o the prediction of loops at these posi- 
tions. When the analysis is extended to hMPO a further 
10 insertions are observed (Table II). Nine of these fall 
within turn/coil regions. The exception is the insertion 
at position 54 of h/pTPO which occurs in the middle of 
a strongly predicted helix. 
(ii) Intron/exon boundaries. Recently the gene struc- 
tures for hTPO and hMPO have been described [12,13]. 
The hTPO gene comprises 17 exons whilst the hMPO 
gene consists of 12 exons. When the exon-intron boun- 
daries of these two genes are compared, exons 3-11 of 
TPO and exons 2-11 of MPO coincide exactly except 
that exon 8 of TPO corresponds to exons 7 and 8 of 
MPO [13]. The use of sequence alignment and exon- 
intron boundaries between related proteins has 
previously been used to predict successfully the domain 
organization of fl,y-crystallins [32] and immunoglo- 
bulins [33]. 
The position of the exon boundaries i illustrated on 
Fig. 2 and summarised in Table II. Between positions 1 
and 741, ten out of the eleven boundaries fall within one 
residue of a strongly predicted turn, or within a coil 
region. 
In the C-terminal region of h/pTPO (742-943) the 
secondary structure of the EGF-like region (795-847) 
may be defined with confidence from the known three- 
dimensional structure of EGF as determined by NMR 
[34] (see below). The 13-14 boundary coincides with the 
random coil N-terminus of EGF, whilst the 14-15 
boundary lies in a very short ~'-strand segment near the 
C-terminus of EGF. The remaining 3 boundaries (out- 
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Table II 
Insertion in Amino acids Alignment Comments 
protein(s) position 
h/pTPO FF 
FF 19-20 
h/pTPO W 
G 31 
h/pTPO M 
1 54 
hMPO LRS 66-68 
h/pTPO TCL 
TCL 148-150 
hMPO P 279 
h/pTPO QGALFGNLST 
QGALVGNLSW 305-314 
h/pTPO A 
A 378 
h/pTPO PGE 
PA 386-388 
h/pTPO S 
S 490 
hTPO L 518 
hMPO I 713 
pTPO GK 896-897 
pTPO LPG 903-904 
Adjacent Pro; turn predicted 
Adjacent Gly; turn predicted 
Predicted helix 
Adjacent Gly; turn predicted 
Turn predicted 
Adjacent Pro; turn predicted 
Turn predicted 
Adjacent Pro; turn predicted 
Turn predicted 
Coil predicted 
Gly/Pro region and predicted turn 
Coil predicted 
Gly/Pro region and predicted turn 
Gly/Pro region and predicted turn 
side the EGF homology region) all lie in predicted turn, 
or coil regions. 
(iii) Conservation of  Cys residues. TPO and MPO are 
both known to contain disulphide bridges [14,18]. Of  
the 16 Cys residues conserved between hTPO and 
pTPO in the region 1-741 only those at residue 15 and 
residue 149 are not also conserved in hMPO. The con- 
served Cys residues are not uniformly distributed 
through the protein sequence. Three occur within a 26 
amino acid stretch (136-161), five in a 39 residue stretch 
(262-300) and two within 15 amino acids (379-393) of 
each other. The remaining 4 conserved Cys positions 
are distributed through the region from 602 to 741, at 
602, 659, 700 and 726. 
This extensive conservation of cysteine residues 
strongly supports the contention that TPO and MPO 
are structurally homologous throughout the region of 
TPO that corresponds to the two subunits of MPO. 
(iv) General residue conservation. Although the 3 
proteins share a large number of identical amino acids 
(hTPO versus pTPO=70070 identity; hTPO versus 
hMPO as aligned in Fig. 2 = 50°70 identity), by consider- 
ing a smoothed profile of conservation values (Fig. 3), 
regions where identities and conservative substitutions 
predominate may be identified. These suggest the 
residues most likely to be involved in structural and/or 
functional roles common to all three molecules. Con- 
versely, regions of low conservation can indicate 
variable regions that may correspond to surface loops, 
or domains that do not exhibit similar functions in all 
three proteins. With one exception, at position 115 
where a turn is also strongly predicted, the most signifi- 
cant minima shown on Fig. 3 correspond to the posi- 
tions of insertions in one or more proteins. The regions 
bounded by these minima are discussed in more detail 
below. 
3.2.4. Homology with EGF, complement C4b and 
cytochrome c oxidase 
Database scans have revealed sequence similarity be- 
tween TPO and EGF [10] in the region 799-847 (Fig. 2). 
The high sequence similarity between the two molecules 
in this region allows the structure of TPO to be 
predicted confidently by analogy with the NMR struc- 
ture of EGF [34]. In particular this is supported by the 
absolute conservation of the six Cys residues that are 
disulphide-bonded in the EGF molecule. The structure 
of EGF consists of two H-strands and turns held 
together by a cluster of three disulphide bonds [34]. 
The EGF-like domain is preceded by a region 
(744-798) that has similarity to C4h [10] and is followed 
by a predicted transmembrane h lix (852-876). These 3 
regions correspond to exons 13, 14 and 15, respectively. 
hMPO and h /pTPO also share a region of strong 
similarity with cytochrome c oxidase polypeptide I 
(514-571). This does not correspond to a single exon, 
but spans the boundary between exons 9 and l0 and in- 
cludes only a part of each. 
3.3. hMPO subunit organisation 
hMPO is synthesised as a large precursor polypeptide 
which, during intracellular transport, is processed to 
yield mature heavy and light chain subunits of approx- 
imately 65 and 14 kDa, respectively [35]. The tetrameric 
complex of functional hMPO is formed by cleavage of 
the precursor hMPO at 144-145 (Thr-Cys) and 259-260 
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(Gly-Val) to yield two heavy (260-741) and two light 
(145-259) chains. Both cleavage points fall within 
strongly predicted turn regions as might be expected for 
a loop or coil accessible to proteolysis. 
3.4. Prediction of domain locations for the peroxidases 
Proteins of the length of the region common to all 
three peroxidases (1-741) are often divided into several 
structural domains. The subunit structure of hMPO 
clearly suggests at least two distinct domains that by 
analogy may exist in TPO. Supporting evidence for this 
suggestion is the presence of an insertion in TPO close 
to the start of the hMPO small subunit and a glycine- 
rich turn region at the end (Fig. 2). Inspection of the 
conservation profile (Fig. 3) shows the hMPO small 
subunit region to be one of the longest continuous 
regions of conservative substitutions. Additionally, 
both subunits tart with stretches of sequence for which 
little regular secondary structure (a-helix and E-strand) 
is predicted. This may indicate that in TPO these are 
flexible domain linking regions. 
The N-terminal region that precedes the small 
subunit of hMPO (1-144) consists of 6 predicted 
helices. These residues 1-144 may form an independent- 
ly folding domain in h/pTPO.  Fig. 3 shows this 
putative domain (Domain A) to exhibit lower overall 
conservation over its length than is seen over the rest of 
the molecule. This observation is consistent with the 
knowledge that this region is cleaved off in the mature 
hMPO and so, presumably is not subject o the same 
pressure to conserve precise detailed tertiary structure 
as the rest of the molecule. 
The hMPO small subunit spans 114 045-259) 
residues in the alignment with only 5 short helices 
strongly predicted. However, the subunit corresponds 
to a region of continuous high conservation (Fig. 3) as 
would be expected for a domain sharing common pro- 
perties of function or structure. We have labelled the 
hMPO small subunit region, Domain B. 
The region corresponding to the hMPO large subunit 
consists of 481 aligned positions (260-741) which is 
atypically large for a single structural protein unit. The 
secondary structure predictions, conservation analysis 
and homology information suggest that the hMPO 
large subunit region may be subdivided into up to 3 
distinct sub-regions (see Fig. 3). There are two long 
segments of continuous high conservation. The segment 
398-520 includes the highly conserved region, suggested 
by Kimura and Ikeda-Saito [11] to contain the proximal 
histidine at 411 (indicated D on Fig.3). This is followed 
by a second long segment which continues to position 
715 (indicated E on Fig. 3). This region includes the 
stretch of sequence homologous to cytochrome c ox- 
idase polypeptide I [10]. It also includes the longest 
stretch of sequence that is completely conserved in all 3 
sequences which occurs at the exon 10/11 boundary 
(positions 588-599) and includes a conserved His at 
590, strongly suggesting that this His is involved in the 
function of all 3 proteins. In TPO-2 this conserved 
His-590 is spliced out in exon 10 and it is possible that 
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Table III 
Exon/intron boundaries in hTPO and hMPO 
hTPO hMPO 
2-3 1-2 
3-4 2-3 
4-5 3-4 
5-6 4-5 
6-7 5 -6 
7-8 6-7 
7-8 
8-9 8-9 
9-10 9-10 
10-11 10-11 
11-12 11-12 
Coil/turn region and deletion in hMPO 
End of helix-turn region - close to insertion in hMPO 
Strongly predicted turn 
Strongly predicted turn 
Strongly predicted turn/coil 
Coil - insertion in hMPO 
Strongly predicted turn 
Ambiguous helix/fl prediction 
Strong turn/coil prediction 
Strong turn/coil prediction 
Strong turn/coil prediction 
12-13 - Coil 
13-14 - Coil - (from homology to EGF) 
14-15 - fl - (from homology to EGF) 
15-16 - Turn 
16-17 - Turn 
its removal may lead to an enzymatically inactive 
molecule. 
A further highly conserved segment precedes these 
domains D and E, spanning positions 315-380 and 
which we have labelled as Domain C (Fig. 3). Between 
the end of Domain B and the beginning of C there is a 
region of 44 residues (260-314) which shows no regular 
secondary structure, includes the longest insertion be- 
tween TPO and MPO, and is unusually rich in Cys 
residues. At the end of Domain C there is a further 
unusual stretch of sequence (369-386) in which 9 out of 
the 18 residues are proline. We suggest hat this seg- 
ment, at the end of which are found deletions in pTPO 
and hMPO relative to hTPO, marks the boundary with 
Domain D. However, evidence for the boundary be- 
tween Domains D and E cannot be considered con- 
clusive. The breakdown in homology in this region 
around residue 518 which gives rise to  the substantial 
minimum in the conservation profile in Fig. 3 could be 
due to an extensive surface loop feature. 
The C-terminal region of TPO from residue 742 in- 
cludes the segments that bear homology with the C4b 
and EGF (Fig. 2). These segments which correspond to 
exons 13 and 14, may well correspond to independently 
folded domains. They are followed by the predicted 
transmembrane h lix and a short intracellular egion 
for which little or no regular secondary structure is 
predicted. 
3.5. Prediction of antibody and T cell defined epitopes 
The TPO molecule is known to be the target autoan- 
tigen recognized by aAbs from patients with autoim- 
mune thyroid disease. We have used the Hopp and 
Woods hydrophilicity profiles [27] to predict sequences 
of amino acid residues in the TPO molecule which may 
be recognized by antibodies. Since antibody recognition 
by B-lymphocytes invariably requires T cell help, we 
have also predicted sequences of amino acid residues 
that may serve as putative recognition sites for T- 
lymphocyte populations using the patterns described by 
Rothbard and Taylor [29]. (Fig. 2). Distinct T-lym- 
phocyte populations specific for target autoantigens 
have been implicated in the pathogenesis of experimen- 
tally induced and human autoimmune diseases 
[15,16,36]. Furthermore, the ability to predict T cell 
recognition sites for human autoimmune diseases is im- 
portant in defining the specificity of cloned human T 
cells using synthetic polypeptides [37]. The B cell defin- 
ed epitopes were predicted as the top 20 hydrophilic 
peaks (Fig. 1). The two most hydrophilic peaks are 
found at positions 684-697 and 223-230. Interestingly, 
using recombinant TPO preparations which encompass 
different segments of the TPO molecule, our recent 
data have shown that polyclonal antisera to TPO and 
patient's autoantibodies to TPO recognize recombinant 
TPO preparations containing residues 657-767 and 
145-250 [38]. These two recombinant preparations har- 
bour the two most hydrophilic peaks mentioned above. 
In contrast to B cell epitopes, no empirical data are 
available on the T cell epitopes of the TPO molecule 
[39]. However, the amino acid residues comprising the 
T cell sites can now be empirically determined using 
synthetic peptides for stimulation of thyroid gland in- 
filtrating or peripheral blood lymphocytes from thyroid 
disease patients undergoing active disease. 
4. CONCLUSIONS 
In summary, multiple sequence alignment and secon- 
dary structure prediction methods used in conjunction 
with CD spectroscopy of a homologous enzyme in- 
dicate that TPO structure is principally u-helical. These 
data taken together with a knowledge of the exon- 
intron boundaries suggest a model for the domain 
140 
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organization of the hTPO molecule. This domain 
model will allow a systematic approach to the design of 
oligonucleotides for PCR amplification of discrete 
regions of cDNA to generate recombinant TPO 
preparations for immunological [38] and crystallo- 
graphic studies. 
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